Picture of CTC Bio logo

060590 CTC Bio Cashflow Statement

0.000.00%
kr flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapSucker Stock

Annual cashflow statement for CTC Bio, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Annual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited AccountsAnnual Audited Accounts
Standards:
IFRS
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-13,765-22,868-7,9786,040-15,588
Depreciation
Amortisation
Non-Cash Items6,42919,4185,8428,12914,078
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital2,716-1,8562,311-2,6513,779
Change in Accounts Receivable
Change in Inventories
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Other Operating Cash Flow
Cash from Operating Activities1,6755096,45718,2248,216
Capital Expenditures-2,215-1,924-1,674-3,173-1,885
Purchase of Fixed Assets
Other Investing Cash Flow Items12,4653,5053,827151232
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities10,2501,5812,153-3,022-1,653
Financing Cash Flow Items-1,603-2,954-2,591-1,840-2,317
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-1,280-4,846-13,3691,617-6,003
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash10,644-3,096-4,75916,538676